0001104659-20-080567.txt : 20200702
0001104659-20-080567.hdr.sgml : 20200702
20200702161711
ACCESSION NUMBER: 0001104659-20-080567
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Partners Innovation Fund II, L.P.
CENTRAL INDEX KEY: 0001689717
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39343
FILM NUMBER: 201009543
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET, SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-307-2400
MAIL ADDRESS:
STREET 1: 215 FIRST STREET, SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akouos, Inc.
CENTRAL INDEX KEY: 0001722271
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 645 SUMMER STREET, SUITE 200
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-245-5715
MAIL ADDRESS:
STREET 1: 645 SUMMER STREET, SUITE 200
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
a4.xml
4
X0306
4
2020-06-30
1
0001722271
Akouos, Inc.
AKUS
0001689717
Partners Innovation Fund II, L.P.
215 FIRST STREET, SUITE 500
CAMBRIDGE
MA
02142
0
0
1
0
Common Stock
2020-06-30
4
C
0
68501
A
68501
D
Common Stock
2020-06-30
4
C
0
228336
A
296837
D
Common Stock
2020-06-30
4
C
0
79998
A
376835
D
Series Seed Preferred Stock
2020-06-30
4
C
0
68501
0.00
D
Common Stock
68501
0
D
Series A Preferred Stock
2020-06-30
4
C
0
228336
0.00
D
Common Stock
228336
0
D
Series B Preferred Stock
2020-06-30
4
C
0
79998
0.00
D
Common Stock
79998
0
D
On June 30, 2020, the Series Seed Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC is the ultimate general partner of PIF II.
On June 30, 2020, the Series A Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
/s/ Partners Innovation Fund II, L.P. By: Julius Knowles, Authorized Signatory
2020-07-02